Lymphoma Trial, Recruiting NCT07032103 Sponsor: Samsung Medical Center Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07032103
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Hodgkin lymphoma or non-Hodgkin lymphoma, confirmed by a laboratory test (such as a biopsy)
  • You are 20 years of age or older
  • Your doctor has determined that you need chemotherapy given throughout your body (not just locally) with the goal of curing your condition
  • You are willing and able to give written consent to participate in the trial

Who may not be able to join:

  • You have a type of blood cancer that affects the myeloid cells (a different type of blood cancer, such as certain leukemias) (confirm with trial site)
  • You have multiple myeloma (a cancer of plasma cells in the bone marrow)
  • Your treatment plan does not include chemotherapy given throughout your body with the goal of curing your condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +82234101766

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2022
Est. completion
30 December 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Reponse rate; Response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov